Fellow Nermin Salah publishes study on breast cancer prodrugs with support from mentor Bianca Liederer

Fellow Nermin Salah (Egypt, 2013) recently co-authored a publication in the field of drug discovery, crediting her TechWomen professional mentor Bianca Liederer of Genentech with providing helpful support and collaboration to the project. Entitled “Design, synthesis, and metabolite identification of Tamoxifen esterase-activatable prodrugs,” the study explores substances that can improve efficacy and reduce resistance to Tamoxifen, an important medication used in the treatment of hormonal-dependent breast cancers. Though she completed her program nearly ten years ago, Nermin maintains that “once a TechWomen always a TechWomen; you keep the network, support and the spirit.” She shares that Bianca and her team offered valuable assistance throughout the research process, even performing some experiments that would have been a challenge to execute in Egypt. Nermin is currently in the U.S. again as a Hubert Humphrey fellow and fondly reflects that she is “still receiving help and guidance from the whole TechWomen community.”
​